Crowley John F has filed 55 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 57620 shares of AMICUS THERAPEUTICS, INC. ($FOLD) on January 09, 2024.
Activity breakdown: 0 open-market purchases and 32 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Common Stock | 57620 | $0.00 | 995,492.0000 | 295,164,515 | 6.14% | 0.02% |
| Jan. 10, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 31614 | $13.65 | 927,013.0000 | 295,164,515 | 3.30% | 0.01% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 36865 | $13.65 | 958,627.0000 | 295,164,515 | 3.70% | 0.01% |
| March 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 29181 | $13.35 | 638,373.0000 | 295,164,515 | 4.37% | 0.01% |
| Feb. 15, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 31614 | $13.81 | 762,523.0000 | 295,164,515 | 3.98% | 0.01% |
| Feb. 15, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 94969 | $14.00 | 667,554.0000 | 295,164,515 | 12.45% | 0.03% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 31614 | $12.62 | 815,733.0000 | 295,164,515 | 3.73% | 0.01% |
| Feb. 1, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 21596 | $12.67 | 794,137.0000 | 295,164,515 | 2.65% | 0.01% |
| Jan. 22, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 55327 | $12.36 | 847,347.0000 | 295,164,515 | 6.13% | 0.02% |
| Jan. 16, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 31614 | $12.78 | 902,674.0000 | 295,164,515 | 3.38% | 0.01% |
| Jan. 10, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 31614 | $13.65 | 934,288.0000 | 295,164,515 | 3.27% | 0.01% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 36865 | $13.65 | 965,902.0000 | 295,164,515 | 3.68% | 0.01% |
| Jan. 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 10659 | $13.44 | 1,002,767.0000 | 295,164,515 | 1.05% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Common Stock | 144628 | $0.00 | 1,121,843.0000 | 295,164,515 | 14.80% | 0.05% |
| Jan. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 108417 | $13.53 | 1,013,426.0000 | 295,164,515 | 9.66% | 0.04% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Stock Options (right to buy) | 249665 | $0.00 | 249,665.0000 | 295,164,515 | 9999.99% | 0.08% |
| Dec. 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6043 | $12.66 | 942,643.0000 | 289,057,198 | 0.64% | 0.00% |
| Dec. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Common Stock | 34572 | $0.00 | 977,215.0000 | 289,057,198 | 3.67% | 0.01% |
| Dec. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6043 | $11.08 | 948,686.0000 | 289,057,198 | 0.63% | 0.00% |
| Nov. 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6043 | $10.84 | 954,729.0000 | 289,057,198 | 0.63% | 0.00% |
| Nov. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $10.97 | 960,772.0000 | 289,057,198 | 0.63% | 0.00% |
| Oct. 16, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $10.50 | 966,816.0000 | 289,057,198 | 0.62% | 0.00% |
| Oct. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 1600 | $11.71 | 972,860.0000 | 289,057,198 | 0.16% | 0.00% |
| Oct. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 4444 | $11.08 | 974,460.0000 | 289,057,198 | 0.45% | 0.00% |
| Sept. 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $13.06 | 978,904.0000 | 289,057,198 | 0.61% | 0.00% |
| Sept. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $12.98 | 984,948.0000 | 289,057,198 | 0.61% | 0.00% |
| Aug. 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $13.03 | 990,992.0000 | 289,057,198 | 0.61% | 0.00% |
| Aug. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $13.35 | 997,036.0000 | 289,057,198 | 0.60% | 0.00% |
| July 17, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $13.45 | 1,003,080.0000 | 289,057,198 | 0.60% | 0.00% |
| July 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $12.31 | 1,009,124.0000 | 289,057,198 | 0.60% | 0.00% |
| June 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $13.04 | 1,015,168.0000 | 289,057,198 | 0.59% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | Crowley John F | Director | A | Common Stock | 4425 | $0.00 | 11,716.0000 | 0 | 60.69% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | Crowley John F | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $11.36 | 1,021,212.0000 | 289,057,198 | 0.59% | 0.00% |
| May 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $11.18 | 1,027,256.0000 | 289,057,198 | 0.58% | 0.00% |
| May 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $11.80 | 1,033,300.0000 | 289,057,198 | 0.58% | 0.00% |
| April 17, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $11.66 | 1,039,344.0000 | 289,057,198 | 0.58% | 0.00% |
| April 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $11.22 | 1,045,388.0000 | 289,057,198 | 0.57% | 0.00% |
| March 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $11.34 | 1,051,432.0000 | 289,057,198 | 0.57% | 0.00% |
| March 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 4107 | $13.29 | 1,059,413.0000 | 289,057,198 | 0.39% | 0.00% |
| March 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 1937 | $13.69 | 1,057,476.0000 | 289,057,198 | 0.18% | 0.00% |
| Feb. 15, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 6044 | $12.94 | 1,063,520.0000 | 289,057,198 | 0.57% | 0.00% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | M | Common Stock | 83333 | $6.10 | 1,160,284.0000 | 289,057,198 | 7.74% | 0.03% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | M | Common Stock | 56596 | $5.13 | 1,216,880.0000 | 289,057,198 | 4.88% | 0.02% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 147316 | $13.11 | 1,069,564.0000 | 289,057,198 | 12.11% | 0.05% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | M | Stock Options (right to buy) | 83333 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.03% |
| Feb. 1, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | M | Stock Options (right to buy) | 56596 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.02% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Common Stock | 210088 | $0.00 | 1,160,212.0000 | 289,057,198 | 22.11% | 0.07% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 83261 | $12.02 | 1,076,951.0000 | 289,057,198 | 7.18% | 0.03% |
| Jan. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | S | Common Stock | 85102 | $11.43 | 950,124.0000 | 289,057,198 | 8.22% | 0.03% |
| Jan. 4, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 10659 | $12.03 | 1,035,226.0000 | 289,057,198 | 1.02% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 22116 | $11.93 | 812,637.0000 | 289,057,198 | 2.65% | 0.01% |
| Jan. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | F | Common Stock | 21596 | $12.21 | 834,753.0000 | 289,057,198 | 2.52% | 0.01% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Stock Options (right to buy) | 414025 | $0.00 | 414,025.0000 | 289,057,198 | 9999.99% | 0.14% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Crowley John F | Executive Chairman | A | Common Stock | 233248 | $0.00 | 1,045,885.0000 | 289,057,198 | 28.70% | 0.08% |